Lynch & Associates Abbott Laboratories Transaction History

Lynch & Associates

  • $467 Million
  • Q3 2024

A detailed history of Lynch & Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Lynch & Associates holds 56,856 shares of ABT stock, worth $6.55 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
56,856
Previous 57,105 0.44%
Holding current value
$6.55 Million
Previous $5.93 Million 9.25%
% of portfolio
1.39%
Previous 1.35%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$100.07 - $118.13 $24,917 - $29,414
-249 Reduced 0.44%
56,856 $6.48 Million
Q2 2024

Aug 06, 2024
BUY
$100.73 - $112.44 $140,417 - $156,741
1,394 Added 2.5%
57,105 $5.93 Million
Q1 2024

Apr 09, 2024
SELL
$109.52 - $120.96 $297,127 - $328,164
-2,713 Reduced 4.64%
55,711 $6.33 Million
Q4 2023

Jan 08, 2024
SELL
$90.19 - $110.4 $182,724 - $223,670
-2,026 Reduced 3.35%
58,424 $6.43 Million
Q3 2023

Oct 24, 2023
SELL
$95.53 - $114.62 $56,171 - $67,396
-588 Reduced 0.96%
60,450 $5.85 Million
Q2 2023

Oct 24, 2023
SELL
$100.78 - $112.29 $108,237 - $120,599
-1,074 Reduced 1.73%
61,038 $6.65 Million
Q2 2023

Jul 13, 2023
SELL
$100.78 - $112.29 $108,237 - $120,599
-1,074 Reduced 1.73%
61,038 $6.65 Million
Q1 2023

Oct 24, 2023
BUY
$96.86 - $114.01 $104,027 - $122,446
1,074 Added 1.76%
62,112 $6.29 Million
Q1 2023

Apr 04, 2023
SELL
$96.86 - $114.01 $103,833 - $122,218
-1,072 Reduced 1.7%
62,112 $6.29 Million
Q4 2022

Oct 24, 2023
BUY
$95.06 - $111.52 $259,894 - $304,895
2,734 Added 4.52%
63,184 $6.94 Million
Q4 2022

Jan 05, 2023
SELL
$95.06 - $111.52 $48,575 - $56,986
-511 Reduced 0.8%
63,184 $6.94 Million
Q3 2022

Oct 03, 2022
SELL
$96.76 - $112.03 $141,850 - $164,235
-1,466 Reduced 2.25%
63,695 $6.16 Million
Q2 2022

Jul 06, 2022
SELL
$102.07 - $123.37 $39,705 - $47,990
-389 Reduced 0.59%
65,161 $7.08 Million
Q1 2022

Apr 08, 2022
SELL
$114.02 - $139.04 $141,954 - $173,104
-1,245 Reduced 1.86%
65,550 $7.76 Million
Q4 2021

Jan 11, 2022
SELL
$115.53 - $141.46 $27,149 - $33,243
-235 Reduced 0.35%
66,795 $9.4 Million
Q3 2021

Oct 12, 2021
SELL
$116.66 - $129.06 $58,446 - $64,659
-501 Reduced 0.74%
67,030 $7.92 Million
Q2 2021

Jul 21, 2021
SELL
$105.79 - $124.53 $28,351 - $33,374
-268 Reduced 0.4%
67,531 $7.83 Million
Q1 2021

Apr 09, 2021
BUY
$108.84 - $128.23 $31,563 - $37,186
290 Added 0.43%
67,799 $8.13 Million
Q4 2020

Jan 20, 2021
SELL
$105.0 - $114.42 $57,225 - $62,358
-545 Reduced 0.8%
67,509 $7.39 Million
Q3 2020

Oct 21, 2020
BUY
$91.64 - $111.29 $2,291 - $2,782
25 Added 0.04%
68,054 $7.41 Million
Q2 2020

Jul 20, 2020
SELL
$76.57 - $98.0 $57,810 - $73,990
-755 Reduced 1.1%
68,029 $6.22 Million
Q1 2020

Apr 28, 2020
SELL
$62.82 - $91.86 $106,794 - $156,162
-1,700 Reduced 2.41%
68,784 $5.43 Million
Q4 2019

Jan 10, 2020
SELL
$78.51 - $87.4 $62,022 - $69,046
-790 Reduced 1.11%
70,484 $6.12 Million
Q3 2019

Oct 03, 2019
SELL
$81.84 - $88.74 $22,342 - $24,226
-273 Reduced 0.38%
71,274 $5.96 Million
Q2 2019

Jul 19, 2019
SELL
$72.88 - $85.0 $50,432 - $58,820
-692 Reduced 0.96%
71,547 $6.02 Million
Q1 2019

Apr 25, 2019
BUY
$66.22 - $80.06 $4,502 - $5,444
68 Added 0.09%
72,239 $5.78 Million
Q4 2018

Jan 10, 2019
BUY
$65.56 - $74.27 $1.1 Million - $1.24 Million
16,722 Added 30.16%
72,171 $5.22 Million
Q2 2018

Jul 09, 2018
BUY
$57.57 - $63.54 $147,954 - $163,297
2,570 Added 4.86%
55,449 $3.38 Million
Q1 2018

Apr 06, 2018
SELL
$56.27 - $63.62 $56,270 - $63,620
-1,000 Reduced 1.86%
52,879 $3.17 Million
Q4 2017

Jan 04, 2018
SELL
$53.68 - $57.47 $29,148 - $31,206
-543 Reduced 1.0%
53,879 $3.08 Million
Q3 2017

Oct 18, 2017
BUY
$48.06 - $53.64 $2.62 Million - $2.92 Million
54,422
54,422 $2.9 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lynch & Associates Portfolio

Follow Lynch & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email